Patent 7893108 was granted and assigned to President and Fellows of Harvard College on February, 2011 by the United States Patent and Trademark Office.
Disclosed herein are antiviral compounds, such as anti-human cytomegalovirus antiviral compounds, pharmaceutical compositions and antiviral methods.